Marijuana Policy Reform Imminent, Cannabis Traders and Trump Insiders Say

President Donald Trump is seriously considering reclassifying marijuana from a Schedule I drug to Schedule III — on par with mild painkillers — The Washington Post disclosed, Forbes Daily reported.

If cannabis is rescheduled, it would usher in a new future for the $32 billion state-regulated cannabis industry.

Nevertheless, a White House spokesperson told Forbes that “no final decisions have been made” on the issue, contrary to what Trump insiders have revealed to Forbes and other news outlets.

If cannabis is rescheduled, it would mark the most significant change to U.S. drug laws since 1970 and usher in a new future for the $32 billion state-regulated cannabis industry.